Resonant Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard International Dividend Appreciation ETF
VIGI
|
+$5.51M |
| 2 |
BSMN
Invesco BulletShares 2023 Municipal Bond ETF
BSMN
|
+$5.15M |
| 3 |
BSMP
Invesco BulletShares 2025 Municipal Bond ETF
BSMP
|
+$4.91M |
| 4 |
BSMO
Invesco BulletShares 2024 Municipal Bond ETF
BSMO
|
+$4.9M |
| 5 |
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
|
+$4.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$5.14M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.44M |
| 3 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$2.2M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.17M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.3% |
| 2 | Technology | 6.2% |
| 3 | Financials | 5.54% |
| 4 | Consumer Staples | 2.91% |
| 5 | Consumer Discretionary | 2.86% |
Similar funds
Resonant Capital Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Resonant Capital Advisors held 262 positions worth $640M, down 5.1% from $674M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Resonant Capital Advisors deployed $50.2M of net new capital in Q2 2022, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Vanguard International Dividend Appreciation ETF: 75,228 shares worth $5.16M.
By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.3% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $5.14M trimmed.
- Resonant Capital Advisors's largest Q2 2022 buy was Vanguard International Dividend Appreciation ETF: 75,228 shares worth $5.16M.
- Resonant Capital Advisors added most to Invesco S&P MidCap 400 Revenue ETF in Q2 2022, an estimated $4.41M increase.
- Resonant Capital Advisors's biggest Q2 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $5.14M.
- Resonant Capital Advisors fully exited Elanco Animal Health in Q2 2022, selling an estimated $373K.
- Resonant Capital Advisors's ten largest holdings make up 35% of its $640M portfolio in Q2 2022.
- Resonant Capital Advisors opened 38 new positions and closed 25 in Q2 2022.
- Resonant Capital Advisors's portfolio value fell 5.1% quarter-over-quarter to $640M.
Based on Resonant Capital Advisors's 13F filing for Q2 2022, filed 12 Jul 2022.